NASDAQ:RCEL

AVITA Medical (RCEL) Stock Forecast, Price & News

$14.61

+0.03 (+0.21%)

(As of 09/29/2023 08:53 PM ET)

Compare

Today's Range: $14.35
▼
$14.81
50-Day Range: $13.84
▼
$20.79
52-Week Range: $4.41
▼
$21.70

Volume: 251,900 shs
Average Volume: 196,484 shs
Market Capitalization: $372.26 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $28.40

AVITA Medical MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 94.4% Upside
$28.40 Price Target
Short Interest: Bearish
3.80% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.60
Based on 4 Articles This Week
Insider Trading: Acquiring Shares
$89,650 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($1.50) to ($1.30) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.94 out of 5 stars

Medical Sector

689th out of 970 stocks

Surgical & Medical Instruments Industry

76th out of 99 stocks

3.5

Analyst's Opinion

Consensus Rating
AVITA Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $28.40, AVITA Medical has a forecasted upside of 94.4% from its current price of $14.61.
Amount of Analyst Coverage
AVITA Medical has only been the subject of 4 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
3.80% of the float of AVITA Medical has been sold short.
Short Interest Ratio / Days to Cover
AVITA Medical has a short interest ratio ("days to cover") of 5.4.
Change versus previous month
Short interest in AVITA Medical has recently increased by 0.14%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
AVITA Medical does not currently pay a dividend.
Dividend Growth
AVITA Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for RCEL.

2.0

News and Social Media Coverage

News Sentiment
AVITA Medical has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for AVITA Medical this week, compared to 1 article on an average week.
MarketBeat Follows
Only 2 people have added AVITA Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, AVITA Medical insiders have bought 34.98% more of their company's stock than they have sold. Specifically, they have bought $89,650.00 in company stock and sold $66,417.00 in company stock.
Percentage Held by Insiders
Only 1.96% of the stock of AVITA Medical is held by insiders.
Percentage Held by Institutions
Only 29.88% of the stock of AVITA Medical is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for AVITA Medical are expected to grow in the coming year, from ($1.50) to ($1.30) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of AVITA Medical is -12.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of AVITA Medical is -12.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
AVITA Medical has a P/B Ratio of 4.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About AVITA Medical (NASDAQ:RCEL) Stock

AVITA Medical, Inc. operates as a regenerative medicine company in the United States, Australia, Japan, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's skin. Its lead product is RECELL System, a platform technology allows for the preparation and delivery of spray-on skin cells to regenerate natural healthy epidermis, as well as to use in the treatment of acute thermal burns in patients eighteen years and older. AVITA Medical, Inc. has a research agreement with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

RCEL Price History

30 days | 90 days | 365 days | Advanced Chart

RCEL Stock News Headlines

September 27, 2023 | americanbankingnews.com

AVITA Medical's (RCEL) Overweight Rating Reiterated at Cantor Fitzgerald

September 25, 2023 | finance.yahoo.com

AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma

October 2, 2023 | Legacy Research (Ad)

Elon Did It Again: This Could be Bigger than Tesla

Love him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.

September 22, 2023 | fool.com

Avita Medical (ASX: AVH)

September 21, 2023 | finance.yahoo.com

AVITA Medical to Present at the Cantor Global Healthcare Conference

September 15, 2023 | finance.yahoo.com

With 49% stake, AVITA Medical, Inc. (ASX:AVH) seems to have captured institutional investors' interest

September 6, 2023 | finance.yahoo.com

AVITA Medical to Participate in Upcoming Investor Conferences

August 27, 2023 | insidermonkey.com

5 Best Cosmetic Surgery and Aesthetics Stocks to Buy

October 2, 2023 | Legacy Research (Ad)

Elon Did It Again: This Could be Bigger than Tesla

August 23, 2023 | msn.com

Cantor Fitzgerald Reiterates AVITA Medical (RCEL) Overweight Recommendation

August 22, 2023 | markets.businessinsider.com

Expert Ratings for AVITA Medical

August 12, 2023 | finance.yahoo.com

AVITA Medical, Inc. (NASDAQ:RCEL) Q2 2023 Earnings Call Transcript

August 12, 2023 | msn.com

Piper Sandler Maintains AVITA Medical (RCEL) Overweight Recommendation

August 11, 2023 | investing.com

Avita Medical (RCEL) Earnings Dates & Reports

August 10, 2023 | finance.yahoo.com

AVITA Medical Reports Second Quarter Financial Results

August 2, 2023 | msn.com

AVITA Medical (RCEL) Price Target Increased by 14.02% to 26.27

July 28, 2023 | msn.com

B of A Securities Maintains AVITA Medical (RCEL) Buy Recommendation

July 20, 2023 | finance.yahoo.com

AVITA Medical to Announce Second Quarter 2023 Financial Results

July 16, 2023 | finance.yahoo.com

AVITA Medical (ASX:AVH) surges 28% this week, taking five-year gains to 306%

July 14, 2023 | finance.yahoo.com

Strength Seen in Avita Medical Inc. (RCEL): Can Its 20.4% Jump Turn into More Strength?

July 14, 2023 | msn.com

Lake Street Maintains AVITA Medical (RCEL) Buy Recommendation

July 6, 2023 | msn.com

AVITA Medical (RCEL) Price Target Increased by 7.03% to 23.03

June 29, 2023 | finance.yahoo.com

AVITA Medical Submits FDA PMA Supplement for RECELL GO

June 27, 2023 | markets.businessinsider.com

Skin Grafts Disruption: Avita Medical's Regenerative Medicine System Poised to Disrupt Traditional Skin Grafts, Says Analyst

June 27, 2023 | msn.com

Cantor Fitzgerald Initiates Coverage of AVITA Medical (RCEL) with Overweight Recommendation

June 26, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL) and Unicycive Therapeutics (UNCY)

June 20, 2023 | markets.businessinsider.com

Piper Sandler Remains a Buy on Avita Medical (RCEL)

See More Headlines

Receive RCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter.

RCEL Company Calendar

Last Earnings: 8/10/2023
Today: 10/01/2023
Next Earnings (Estimated): 11/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:RCEL
CUSIP: N/A
CIK: 1762303
Web: www.avitamedical.com
Phone: (833) 462-8482
Fax: N/A
Employees: 126
Year Founded: 2008

Price Target and Rating

Average Stock Price Forecast: $28.40
High Stock Price Forecast: $40.00
Low Stock Price Forecast: $23.00
Forecasted Upside/Downside: +94.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.21)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-26,670,000.00
Net Margins: -74.77%
Pretax Margin: -74.60%
Return on Equity: -38.31%
Return on Assets: -32.40%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.61
Quick Ratio: 5.39

Sales & Book Value

Annual Sales: $34.42 million
Price / Sales: 10.82
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.39 per share
Price / Book: 4.31

Miscellaneous

Outstanding Shares: 25,480,000
Free Float: 24,979,000
Market Cap: $372.26 million
Optionable: Not Optionable
Beta: 1.49

Social Links

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. James M. Corbett (Age 65)
CEO, Pres & Exec. Director
Comp: $787.1k

Mr. Andrew Quick (Age 52)
Chief Technology Officer
Comp: $615.86k

Ms. Donna Shiroma (Age 61)
Gen. Counsel & Sec.
Comp: $642.72k

Mr. David O'Toole
Chief Financial Officer

Mr. David Fencil
Sr. VP of Global Operations

Ms. Jessica Ekeberg
Investor Relations Exec.

Ms. Debbie Garner
Sr. VP of Global Marketing & Strategy

Mr. Rob Hall
Sr. VP of HR

Mr. Terry Bromley
Sr. VP of Global Sales

Dr. Niraj Doshi J.D.
P.M.P., Ph.D., Sr. VP of Product Devel. & Program Management

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RCEL Stock - Frequently Asked Questions

Should I buy or sell AVITA Medical stock right now?: 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AVITA Medical in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" RCEL shares.
View RCEL analyst ratings or view top-rated stocks.
What is AVITA Medical's stock price forecast for 2023?: 5 brokers have issued twelve-month price objectives for AVITA Medical's shares. Their RCEL share price forecasts range from $23.00 to $40.00. On average, they predict the company's stock price to reach $28.40 in the next twelve months. This suggests a possible upside of 94.4% from the stock's current price.
View analysts price targets for RCEL or view top-rated stocks among Wall Street analysts.
How have RCEL shares performed in 2023?: AVITA Medical's stock was trading at $6.60 at the beginning of 2023. Since then, RCEL shares have increased by 121.4% and is now trading at $14.61.
View the best growth stocks for 2023 here.
When is AVITA Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our RCEL earnings forecast.
How were AVITA Medical's earnings last quarter?: AVITA Medical, Inc. (NASDAQ:RCEL) announced its quarterly earnings results on Thursday, August, 10th. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.07. The business earned $11.75 million during the quarter, compared to the consensus estimate of $11.20 million. AVITA Medical had a negative net margin of 74.77% and a negative trailing twelve-month return on equity of 38.31%.
What guidance has AVITA Medical issued on next quarter's earnings?: AVITA Medical issued an update on its second quarter 2023 earnings guidance on Thursday, August, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $13.00 million-$14.00 million, compared to the consensus revenue estimate of $12.98 million.

What other stocks do shareholders of AVITA Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other AVITA Medical investors own include NVIDIA (NVDA), Block (SQ), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), PayPal (PYPL), Twilio (TWLO), AbbVie (ABBV), Inovio Pharmaceuticals (INO) and Livongo Health (LVGO).
What is AVITA Medical's stock symbol?: AVITA Medical trades on the NASDAQ under the ticker symbol "RCEL."
How do I buy shares of AVITA Medical?: Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is AVITA Medical's stock price today?: One share of RCEL stock can currently be purchased for approximately $14.61.
How much money does AVITA Medical make?: AVITA Medical (NASDAQ:RCEL) has a market capitalization of $372.26 million and generates $34.42 million in revenue each year. The company earns $-26,670,000.00 in net income (profit) each year or ($1.21) on an earnings per share basis.
How many employees does AVITA Medical have?: The company employs 126 workers across the globe.
How can I contact AVITA Medical?: AVITA Medical's mailing address is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. The official website for the company is www.avitamedical.com. The company can be reached via phone at (833) 462-8482 or via email at investor@avitamedical.com.

This page (NASDAQ:RCEL) was last updated on 10/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial